rbf absorption was studied following oral administration of 150mg rbf as 5'-phosphate flavin mononucleotide in ten clinically complete quadriplegic patients ( c1 to c7 , two to 15 months post-onset ) and six control subjects matched for age , sex , and weight .
C0035527
rbf
C0016388
flavin mononucleotide